Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 202077
Company: CARNEGIE

Products on ANDA 202077

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
LATANOPROST	LATANOPROST	0.005%	SOLUTION/DROPS;OPHTHALMIC	Prescription	AT	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 202077

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
02/11/2013	ORIG-1	Approval	Not Applicable			Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
02/11/2013	SUPPL-11			Label is not available on this site.
12/17/2015	SUPPL-1	Labeling-Package Insert		Label is not available on this site.

Therapeutic Equivalents for ANDA 202077

LATANOPROST

SOLUTION/DROPS;OPHTHALMIC; 0.005%
TE Code = AT

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
LATANOPROST	LATANOPROST	0.005%	SOLUTION/DROPS;OPHTHALMIC	Prescription	No	AT	200925	AMRING PHARMS
LATANOPROST	LATANOPROST	0.005%	SOLUTION/DROPS;OPHTHALMIC	Prescription	No	AT	201006	BAUSCH AND LOMB
LATANOPROST	LATANOPROST	0.005%	SOLUTION/DROPS;OPHTHALMIC	Prescription	No	AT	202077	CARNEGIE
LATANOPROST	LATANOPROST	0.005%	SOLUTION/DROPS;OPHTHALMIC	Prescription	No	AT	202442	FDC LTD
LATANOPROST	LATANOPROST	0.005%	SOLUTION/DROPS;OPHTHALMIC	Prescription	No	AT	091449	SANDOZ
LATANOPROST	LATANOPROST	0.005%	SOLUTION/DROPS;OPHTHALMIC	Prescription	No	AT	201786	SOMERSET
XALATAN	LATANOPROST	0.005%	SOLUTION/DROPS;OPHTHALMIC	Prescription	Yes	AT	020597	UPJOHN